FEATURED STORIES

News

The Supreme Court will determine how a fish oil pill shakes up the generics market

Endpoints News | April 28, 2026

When the Supreme Court hears arguments this week over a prescription-strength pill derived from fish oil, the entire generic drug industry will be watching.

The case could have broad implications on how new generics get sold, and how long brand-name drug manufacturers can defend their monopolies. Hikma launched a generic version of Amarin's heart drug Vascepa in 2020, but only for one indication: severe hypertriglyceridemia. To avoid infringing Vascepa's patents, Hikma left the drug's newer — and bigger — indication of reducing cardiovascular risk off its label.

It's a commonly used practice called "skinny labeling," which allows generic drugs to launch years before they otherwise would by carving out patented indications from the label. But Amarin has accused Hikma of encouraging physicians to prescribe its generic drug for heart risk anyway, undermining its patent protections.

READ

ABOUT ME

Let's connect!

I am a senior reporter at Endpoints News, a leading news source for the biopharma industry and a publication of the Financial Times. I cover a variety of breaking news, features and health policy-related stories, particularly around the Inflation Reduction Act. I'm also a co-author of Endpoints Weekly, a newsletter that recaps the week's biggest news in biopharma.

Before Endpoints, I was a breaking news and general assignment reporter at the Lowell Sun. My coverage spanned court stories, local politics, early pandemic updates and more. I helped launch the Daily Sunrise, a curated morning newsletter that gained more than a thousand new subscribers in just a few months.

I'm a proud University of Massachusetts Amherst graduate with a degree in journalism and a minor in information technology. I've also written for the Boston Globe Magazine, Daily Hampshire Gazette, and Worcester Telegram & Gazette. When I'm not on deadline, you'll find me making homemade pasta or lost in a good book.

About